10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2012

or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ____ _ .

Commission File No. 0-147

HICKOK INCORPORATED
_____________________________________________________________
(Exact name of registrant as specified in its charter)

Ohio	34-0288470
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
10514 Dupont Avenue, Cleveland, Ohio	44108
(Address of principal executive offices)	(Zip Code)
(Registrant's telephone number, including area code)	(216) 541-8060

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes X No___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer,""accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]
Non-accelerated filer   [ ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No_X_

As of February 8, 2013:  1,163,349 Hickok Incorporated Class A Common Shares and 474,866 Class B Common Shares were outstanding.

PART I. - FINANCIAL INFORMATION

Item 1. Financial Statements.

HICKOK INCORPORATED
CONSOLIDATED INCOME STATEMENTS
(Unaudited)

Three months ended
December 31,

	2012	2011
Net Sales
Product Sales	$1,647,435	$1,110,740
Service Sales	91,468	70,761
Total Net Sales	1,738,903	1,181,501
Costs and Expenses
Cost of Product Sold	892,133	729,105
Cost of Service Sold	34,269	59,684
Product Development	231,147	224,737
Marketing and Administrative      Expenses	417,243	349,641
Interest Charges	22,855	3,995
Other Income	(2,548)	(2,521)
Total Costs and Expenses	1,595,099	1,364,641
Income (Loss) before Provision for Income Taxes	143,804	(183,140)
Provision for (Recovery of) Income Taxes	-	-
Net Income (Loss)	$143,804	$(183,140)
Earnings per Common Share:
Net Income (Loss)	$.09	$(.15)
Earnings per Common Share Assuming Dilution:
Net Income (Loss)	$.09	$(.15)
Dividends per Common Share	$-0-	$-0-

See Notes to Consolidated Financial Statements

HICKOK INCORPORATED CONSOLIDATED BALANCE SHEET

	December 31, 2012 (Unaudited)	September 30, 2012 (Note)	December 31, 2011 (Unaudited)
Assets
Current Assets
Cash and Cash Equivalents	$156,212	$258,798	$826,348
Trade Accounts Receivable-Net	1,129,405	702,846	566,386
Notes Receivable-Current	3,600	3,600	2,400
Inventories	1,870,119	1,734,770	1,833,416
Prepaid Expenses	73,816	123,957	89,457
Total Current Assets	3,233,152	2,823,971	3,318,007
Property, Plant and Equipment
Land	233,479	233,479	233,479
Buildings	1,429,718	1,429,718	1,429,718
Machinery and Equipment	2,374,319	2,374,319	2,346,024
	4,037,516	4,037,516	4,009,221
Less: Allowance for Depreciation	3,714,001	3,688,266	3,641,412
Total Property - Net	323,515	349,250	367,809
Other Assets
Notes Receivable-Long-term	30,100	31,000	34,900
Deposits	1,750	1,750	1,750
Total Other Assets	31,850	32,750	36,650
Total Assets	$3,588,517	$3,205,971	$3,722,466

Note: Amounts derived from audited financial statements previously filed with the
Securities and Exchange Commission.

See Notes to Consolidated Financial Statements 

	December 31, 2012 (Unaudited)	September 30, 2012 (Note)	December 31, 2011 (Unaudited)
Liabilities and Stockholders' Equity
Current Liabilities
Short-Term Financing	$100,000	$-	$250,000
Convertible Notes Payable	-	208,591	233,441
Trade Accounts Payable	292,341	178,835	143,156
Accrued Payroll & Related Expenses	132,443	149,636	122,905
Accrued Expenses	323,365	306,475	199,312
Accrued Taxes Other Than Income	59,432	44,559	62,680
Accrued Income Taxes	-	-	-
Total Current Liabilities	907,581	888,096	1,011,494
Long-Term Financing	-	-	-
Stockholders' Equity
Class A, no par value;    authorized 10,000,000 shares;    1,163,349 shares outstanding    (1,045,597 shares outstanding    at September 30, 2012 and    919,412 December 31, 2011)    excluding 15,795 shares    in treasury	1,261,188	1,045,597	919,412
Class B, no par value;    authorized 2,500,000 shares;    474,866 shares outstanding    (474,866 at September 30, 2012    and December 31, 2011)excluding    667 shares in treasury	474,866	474,866	474,866
Preferred, no par value;    authorized 1,000,000 shares;    no shares outstanding	-	-	-
Contributed Capital	1,413,306	1,409,640	1,328,096
Retained Earnings	(468,424)	(612,228)	(11,402)
Total Stockholders' Equity	2,680,936	2,317,875	2,710,972
Total Liabilities and Stockholders' Equity	$3,588,517	$3,205,971	$3,722,466

HICKOK INCORPORATED
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE THREE MONTHS ENDED DECEMBER 31,
(Unaudited)

	2012	2011
Cash Flows from Operating Activities:
Cash received from customers	$1,312,344	$1,337,846
Cash paid to suppliers and employees	(1,493,998)	(1,277,898)
Interest paid	-	(3,950)
Interest received	93	170
Net Cash Provided By (Used In) Operating          Activities	(181,561)	56,168
Cash Flows from Investing Activities:
Capital expenditures	-	(9,029)
Payments received on notes receivable	900	800
Net Cash Provided By (Used In) Investing           Activities	900	(8,229)
Cash Flows from Financing Activities:
Cost for additional Authorized shares	(21,925)	-
Increase in Short-term borrowings	100,000	-
Increase in Convertible Notes Payable	-	466,879
Sale of Class B shares from treasury	-	37,000
Net Cash Provided By (Used In) Financing          Activities	78,075	503,879
Net increase (decrease) in cash and cash equivalents	(102,586)	551,818
Cash and cash equivalents at beginning of year	258,798	274,530
Cash and cash equivalents at end of first quarter	$156,212	$826,348
See Notes to Consolidated Financial Statements
	2012	2011
Reconciliation of Net Income (Loss) to Net Cash  Provided By (Used In) Operating Activities:
Net Income (Loss)	$143,804	$(183,140)
Adjustments to reconcile net income (loss) to       net cash provided by operating activities:
Depreciation	25,735	27,499
Non-cash share-based compensation expense	2,841	2,865
Non-cash professional service expense	7,000	-
Non-cash interest expense	22,750	-
Deferred income taxes	-	-
Changes in assets and liabilities:
Decrease (Increase) in accounts                receivable	(426,559)	156,345
Decrease (Increase) in inventories	(135,349)	130,527
Decrease (Increase) in prepaid expenses	50,141	(36,190)
Increase (Decrease) in accounts payable	113,506	(30,692)
Increase (Decrease) in accrued payroll                and related expenses	(17,193)	(20,044)
Increase (Decrease) in accrued expenses                and accrued taxes other than income	31,763	8,998
Total Adjustments	(325,365)	239,308
Net Cash Provided By (Used In)                   Operating Activities	$(181,561)	$56,168
Supplemental Schedule of Non-Cash Financing Activities:
Conversion of convertible notes payable       to Class A shares	$208,591	$233,438

HICKOK INCORPORATED
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
DECEMBER 31, 2012

1. Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended December 31, 2012 are not necessarily indicative of the results that may be expected for the year ended September 30, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended September 30, 2012.

2. Inventories

Inventories are valued at the lower of cost or market and consist of the following:

	December 31, 2012	September 30, 2012	December 31, 2011
Components	$1,036,824	$1,061,957	$1,051,776
Work-in-Process	596,926	451,733	486,813
Finished Product	236,369	221,080	294,827
	$1,870,119	$1,734,770	$1,833,416

The above amounts are net of reserve for obsolete inventory in the amount of $883,903, $851,000 and $762,000 for the periods ended December 31, 2012, September 30, 2012 and December 31, 2011 respectively.

3. Notes Receivable

The Company has notes receivable with a current and former employee at an interest rate of three percent per annum. The Company does not anticipate repayment within the next twelve months.

4. Convertible Notes Payable

On December 30, 2011, Hickok Incorporated entered into a Convertible Loan Agreement with Roundball, LLC and the Aplin Family Trust. Under the Convertible Loan Agreement, the Company issued a convertible note to Roundball in the amount of $466,879 and a convertible note to the Aplin Family Trust in the amount of $208,591. In addition, Roundball, LLC shall have the right to cause the Company to borrow up to an additional $466,880 from Roundball, LLC. The notes were unsecured, bore interest at a rate of 0.20% per annum and were set to mature on December 30, 2012.

In addition, the Company sold 20,000 Class B Common Shares currently held in treasury to Roundball at a price of $1.85 per share per a subscription agreement between the Company and Roundball dated December 30, 2011.

The notes were convertible by the Investors at any time into Class A Common Shares of the Company, at a conversion price of $1.85 per share, although up to no more than 504,735 Conversion Shares for Roundball and no more than 112,752 Conversion Shares for the Aplin Family Trust. The Company had the option to convert the notes at the expiration date, if the investors had not during the course of the agreement. On December 30, 2011, Roundball converted $233,438 into Class A Common Shares of the Company. In addition, on August 20, 2012 Roundball converted the remaining $233,441 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 28, 2012, the Aplin Family Trust converted the $208,591 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 30, 2012 management entered into an amended Convertible Loan Agreement with Roundball which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2012 to December 31, 2013 and modifying the terms to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.24%.

In partial consideration for Amendment No. 1, the Company and Roundball entered into a Warrant Agreement, dated  December 30, 2012, whereby the Company issued a warrant to the Roundball to purchase, at its option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015. Roundball is an affiliate of Steven Rosen, a Director of the Company.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued is amortized over the one year amended convertible loan agreement period. During the quarter ended December 31, 2012, $11,375 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the three month period ended December 31, 2012: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

5. Short-term Financing

The Company had a credit agreement of $250,000 with Robert L. Bauman, one of its major shareholders who is also an employee of the Company. The agreement was to expire in April 2013 but was modified on December 31, 2012 to extend the maturity date to December 2013. Effective October 30, 2012 for the remainder of the agreement, the lender may terminate the agreement with 45 days written notice, but it is at the discretion of the Company to deny the termination notice until December 2013 if it will have a negative effect on the solvency of the Company.

The agreement provides for a revolving credit facility of $250,000 with interest at 0.24% per annum and is unsecured and includes a three year warrant for 100,000 shares of Class A common stock at a price of $2.50 per share. In addition, the agreement generally allows for borrowing based on an amount equal to eighty percent of eligible accounts receivables or $250,000. The Company had outstanding borrowings of $100,000 under this loan facility at December 31, 2012.

In partial consideration for the extension of the revolving credit facility the Company and Bauman entered into a Warrant Agreement, dated December 30, 2012 whereby the Company issued a warrant to Bauman to purchase, at his option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued is amortized over the one year credit agreement period. During the quarter ended December 31, 2012, $11,375 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the three month period ended December 31, 2012: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

6. Capital Stock, Treasury Stock, Contributed Capital and Stock Options

Under the Company's Key Employees Stock Option Plans (collectively the "Employee Plans"), incentive stock options, in general, are exercisable for up to ten years, at an exercise price of not less than the market price on the date the option is granted. Under the Employee Plans there are no options currently available for grant and there are no options outstanding at December 31, 2012. Options for 26,850 Class A shares were outstanding at December 31, 2011 at a price of $3.55 per share.

The Company's Outside Directors Stock Option Plans (collectively the "Directors Plans"), provide for the automatic grant of options to purchase up to 38,000 shares of Class A Common Stock to members of the Board of Directors who are not employees of the Company, at the fair market value on the date of grant. Options for 42,000 Class A shares were outstanding at December 31, 2012 (42,000 shares at September 30, 2012 and 38,000 shares at December 31, 2011) at prices ranging from $2.925 to $11.00 per share. All outstanding options under the Directors Plans become fully exercisable on March 8, 2015.

The following is a summary of the range of exercise prices for stock options outstanding and exercisable under the Directors Plans at December 31, 2012:

   

Directors Plans	Outstanding Stock Options	Weighted Average  Share Price	Weighted Average Remaining Life	Number of Stock Options  Exercisable	Weighted Average Share Price
Range of exercise prices:
$2.925 - $5.25	23,000	$3.43	6.3	12,667	$3.84
$6.00 - $7.25	11,000	$6.46	4.3	9,333	$6.55
$10.50 - $11.00	8,000	$10.75	4.8	8,000	$10.75
	42,000	$5.62		30,000	$6.52

The Company accounts for Share-Based Payments under the modified prospective method for its stock options for both employees and non-employee Directors. Compensation cost for fixed based awards are measured at the grant date, and the Company uses the Black-Scholes option pricing model to determine the fair value estimates for recognizing the cost of employee and director services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. Employee stock options were immediately exercisable while Director's stock options are exercisable over a three year period. The fair value of stock option grants to Directors is amortized over the three year vesting period. During the quarter ended December 31, 2012 $2,841 was expensed as share-based compensation. During the quarter ended December 31, 2011 $2,865 was expensed as share-based compensation. The following weighted-average assumptions were used in the option pricing model for the three month periods ended December 31, 2012 and 2011 respectively: a risk free interest rate of 5.5% and 5.5%; an expected life of 10 and 10 years; an expected dividend yield of 0.0% and 0.0%; and a volatility factor of .87 and .75.

On October 11, 2012, the Company's Amended Articles of Incorporation and the Amended Code of Regulations were adopted by an affirmative vote of more than two-thirds of the Company's Class A and Class B Shareholders.

The Amended Articles amend and restate the Current Articles in a number of significant ways and are primarily as follows: increased the number of Class A Shares and Class B Shares from 3,750,000 and 1,000,000 to 10,000,000 and 2,500,000 respectively, and added a class of 1,000,000 Serial Preferred Shares; eliminated par value for for Class A Shares and Class B Shares; updated certain provisions relating to the payment of dividends; removed restrictions on the issuance of additional Class A Shares; clarified the method by which the Company may repurchase its shares; reduced the percentage of shareholder vote required to authorize corporate actions from two-thirds of the voting power to a majority of the voting power; and made other technical or conforming changes.

The Amended Regulations amend and restate the Current Regulations in a number of significant ways and are primarily as follows: updated certain provisions relating to the Company's meetings of shareholders in order to provide more consistency in the regulations regarding the Company's practices in this area; further clarifying the roles of the Company's officers and directors in conducting the Company's business; updated the Company's policy regarding the indemnification of its directors, officers, employees, and others; revised provisions allowing for the Board of Directors to adopt amendments to the Amended Regulations to the extent permitted by Ohio law; and made other technical or conforming changes.  

Detailed information related to the two changes approved by shareholders may be found in the 2012 Proxy Statement for the Special Meeting held October 11, 2012 which was filed with the Securities and Exchange Commission on September 14, 2012.

Unissued shares of Class A common stock (769,233 shares) are reserved for the share-for-share conversion rights of the Class B common stock, stock options under the Directors Plans, conversion rights of the Convertible Promissory Note and available warrants.

7. Recently Issued Accounting Pronouncements

The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.

8. Earnings per Common Share

Earnings per common share information is computed on the weighted average number of shares outstanding during each period based on the provisions of FASB Codification ASC Topic 260, "Earnings per Share."  The required reconciliations are as follows:

	Three Months ended December 31,
	2012	2011
Basic Income (Loss) per Share
Income (Loss) available to common stockholders	$143,804	$(183,140)
Shares denominator	1,528,541	1,251,273
Per share amount	$.09	$(.15)
Effect of Dilutive Securities
Average shares outstanding	1,528,541	1,251,273
Stock options	12,942	-
	1,541,483	1,251,273
Diluted Income (Loss) per Share
Income (Loss) available to common stockholders	$143,804	$(183,140)
Per share amount	$.09	$(.15)

Options and warrants to purchase 42,000 and 200,000 shares of common stock respectively during the first quarter of fiscal 2013 at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

Options to purchase 64,850 shares of common stock during the first quarter of fiscal 2012 at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In addition, conversion rights to purchase 491,304 shares of common stock at a price of $1.85 per share were not included in the computation of diluted earnings per share during the first quarter of fiscal 2012 because the conversion rights of the Convertible Promissory Notes effect was antidilutive or the exercise price was greater than the average market price of the common share.


9. Segment and Related Information

The Company's four business units have a common management team and infrastructure that offer different products and services. The business units have been aggregated into two reportable segments: 1.)indicators and gauges and 2.)automotive related diagnostic tools and equipment.

Indicators and Gauges
This segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to both original equipment manufacturers and to operators of railroad equipment.

Automotive Diagnostic Tools and Equipment
This segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEM's and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions.

Information by industry segment is set forth below:

Three Months Ended
December 31,

	2012	2011
Net Sales
Indicators and Gauges	$410,226	$378,003
Automotive Diagnostic Tools and Equipment	1,328,677	803,498
	$1,738,903	$1,181,501
Income (Loss) before Provision for Income Taxes
Indicators and Gauges	$111,624	$57,465
Automotive Diagnostic Tools and Equipment	307,465	(15,256)
General Corporate Expenses	(275,285)	(225,349)
	$143,804	$(183,140)
Asset Information
Indicators and Gauges	$831,059	$729,421
Automotive Diagnostic Tools and Equipment	2,167,252	1,667,391
Corporate	590,206	1,325,654
	$3,588,517	$3,722,466
Geographical Information
Included in the consolidated financial statements are the following amounts related to geographical locations:
Revenue:
United States	$1,700,435	$1,112,633
Australia	-	12,053
Canada	28,054	13,752
Taiwan	-	32,405
Other foreign countries	10,414	10,658
	$1,738,903	$1,181,501

All export sales to Australia, Canada, Taiwan and other foreign countries are made in United States of America Dollars.

10. Commitments and Contingencies

Legal Matters

The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the Company's results of operations, financial position or cash flows.

The Company is a named defendant along with numerous other companies in a suit in the State of Michigan regarding asbestos harm to the plaintiff. The Company has engaged a Michigan attorney to provide representation. The Company believes the suit is without merit and is pursuing dismissal of the case.

11. Subsequent Events

The Company has evaluated subsequent events through February 7, 2013, which is the date the financial statements were available to be issued, and has determined there were no subsequent events to recognize or disclose in these financial statements.

12. Business Condition and Management Plan

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has suffered recurring losses from operations during the past several years due primarily to decreasing sales of existing product lines and a general economic downturn in all markets the Company serves.

The ability of the Company to continue as a going concern is dependent on improving the Company's profitability and cash flow and securing additional financing if needed. Management continues to review and revise its strategic plan and believes in the viability of its strategy to increase revenues and profitability through increased sales of existing products and the introduction of new products to the market place. Management believes that the actions presently being taken by the Company will provide the stimulus for it to continue as a going concern, however, because of the inherent uncertainties there can be no assurances to that effect. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management took steps to reduce expenses throughout the Company in fiscal 2009, 2010 and 2011 in the form of substantial reductions in personnel, wage reductions for all personnel and expenditure restrictions in most aspects of the Company’s operations. Anticipated cost savings were achieved during the past four years and management expects these measures to continue through fiscal 2013. During the first quarter of fiscal 2012 management entered into two unsecured convertible loan agreements that have provided approximately $675,000 of cash to date. One of the convertible loan agreements was fully converted during fiscal 2012 and the other on December 28, 2012.

In addition, on December 30, 2012 management entered into an amended unsecured convertible loan agreement and an additional revolving line of credit which may provide approximately $717,000 of liquidity to meet on going working capital requirements. One agreement is an unsecured revolving line of credit with a major shareholder who is also an employee and the other is an unsecured convertible loan agreement with a major shareholder who is also a Director as discussed in Notes 4 and 5. These facilities are available through December 2013.

The above available financing resources together with management’s revised strategic plan to increase revenues and profitability through increased sales of existing products, the introduction of new products to the market place and the large order from a Tier 1 Supplier should provide the Company with the needed working capital for the foreseeable future.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Results of Operations, First Quarter (October 1, 2012 through December 31, 2012)
Fiscal 2013 Compared to First Quarter Fiscal 2012
-----------------------------------------------------------------------------------------

Reportable Segment Information

The Company has determined that it has two reportable segments: 1)indicators and gauges and 2)automotive related diagnostic tools and equipment. The indicators and gauges segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business, military and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to original equipment manufacturers, servicers of locomotives and operators of railroad equipment. Revenue in this segment was $410,226 and $378,003 for the first quarter of fiscal 2013 and fiscal 2012, respectively. The automotive diagnostic tools and equipment segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEM's and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions. Revenue in this segment was $1,328,677 and $803,498 for the first quarter of fiscal 2013 and fiscal 2012, respectively.

Results of Operations

Product sales for the quarter ended December 31, 2012 were $1,647,435 versus $1,110,740 for the quarter ended December 31, 2011. The increase in product sales during the current quarter of approximately $537,000 was volume related due primarily to increased sales of automotive diagnostic testing products to OEM's of approximately $681,000 and indicator products of approximately $30,000 offset by a decrease in sales of non-emission aftermarket products and emissions testing products of approximately $96,000 and $78,000 respectively. Product sales are expected to continue at current levels for the second quarter due to the completion of the large order in January 2013. Management continues to be concerned about the current economic conditions in the markets the Company serves. Although the current economic uncertainties make forecasting difficult, product sales are expected to decrease slightly during the third and fourth quarter of fiscal 2013.

Service sales for the quarter ended December 31, 2012 were $91,468 versus $70,761 for the quarter ended December 31, 2011. The increase was volume related and due primarily to a higher sales volume for chargeable repairs. The current level of service sales related to product repair sales is expected to decrease slightly for the balance of the fiscal year.

Cost of product sold in the first quarter of fiscal 2013 was $892,133 (54.2% of product sales) as compared to $729,105 (65.6% of product sales) in the first quarter of fiscal 2012. The decrease in the cost of product sold percentage was due primarily to a change in product mix. The dollar increase is due to the volume increase of product sales during the current quarter. The current cost of product sold percentage is expected to continue for the second quarter and increase slightly for the third and fourth quarters.

Cost of service sold in the first quarter of fiscal 2013 was $34,269 (37.5% of service sales) as compared to $59,684 (84.3% of service sales) in the first quarter of fiscal 2012. The percentage decrease was due primarily to a higher sales volume and product specifics of chargeable repairs. The current cost of services sold percentage is expected to increase slightly for the balance of the fiscal year.

Product development expenses were $231,147 in the first quarter of fiscal 2013 (14.0% of product sales) as compared to $224,737 (20.2% of product sales) in the first quarter of fiscal 2012. The percentage decrease was due primarily to higher product sales during the current quarter. The current level of product development expenses is expected to continue for the balance of the fiscal year. The Company believes the existing resources will be sufficient to continue to develop identified new products for both OEM and Aftermarket customers.

Marketing and administrative expenses were $417,243 (24.0% of total net sales) in the first quarter of fiscal 2013 versus $349,641 (29.6% of total net sales) for the same period a year ago. The percentage decrease was due primarily to the higher level of total sales for the current quarter. Marketing expenses were approximately $162,000 in the first quarter of fiscal 2013 versus $126,000 for the same period a year ago. Within marketing expenses, wages, royalty expense, consulting expense and advertising expenses increased by approximately $17,000, $19,000, $2,000 and 1,000 respectively. Credit and collection expense decreased by approximately $2,000. Administrative expenses were approximately $255,000 in the first quarter of fiscal 2013 versus $224,000 for the same period a year ago. Within administrative expenses professional fees and wages increased approximately $33,000 and $4,000 respectively. The increases were offset in part by decreases in repairs and maintenance expenses, and directors fees and expenses, of approximately $7,000 and $1,000 respectively. The current level of marketing and administrative expenses are expected to continue for the balance of the fiscal year.

Interest expense was $22,855 in the first quarter of fiscal 2013 which compares with $3,995 in the first quarter of fiscal 2012. The increase in interest charges in the current quarter compared to a year ago was due to recording as non-cash interest expense the present value of one fourth of the warrants issued in December 2012. Interest on the line of credit borrowing declined by approximately $3,900 during the current fiscal year. The current level of interest expense is anticipated to continue for the remainder of the fiscal year.

Other income was $2,548 in the first quarter of fiscal 2013 which compares with $2,521 in the first quarter of fiscal 2012. Other income consists primarily of interest income on cash and cash equivalents invested and the proceeds from the sale of scrap metal shavings.

Income taxes in the first quarter of fiscal 2013 was $0 which compares with income taxes of $0 in the first quarter of fiscal 2012. In the first quarter of fiscal 2013 income taxes were recorded at an effective tax rate of 37% offset by deferred taxes, specifically the carryforward of net operating loss carryforwards. In the first quarter of fiscal 2012 recovery of income taxes was calculated at an effective tax rate of 37% offset by a increase in the valuation allowance netting to $0.

Net income in the first quarter of fiscal 2013 was $143,804 which compares with a net loss of $183,140 in the first quarter of fiscal 2012. The net income in fiscal 2013 was due primarily to a higher sales volume.
 
Management took steps to reduce expenses throughout the Company in fiscal 2009, 2010 and 2011 in the form of substantial reductions in personnel, wage reductions for all personnel and expenditure restrictions in most aspects of the Company's operations. Anticipated cost savings were achieved during the past four years and during the current quarter ended December 31, 2012. Management expects these measures to continue through fiscal 2013. In addition, the Board of Directors reduced and then eliminated all Board of Directors fees until Company financial conditions improve.

Unshipped customer orders as of December 31, 2012 were $1,372,000 versus $659,000 at December 31, 2011. The $713,000 increase was due primarily to increased orders for automotive diagnostic products to OEM's and aftermarket products which include emissions products of approximately $667,000 and $36,000 respectively. In addition, orders for indicator products also increased by approximately $10,000. The Company anticipates that most of the current backlog will be shipped in fiscal 2013. 

Liquidity and Capital Resources

Total current assets were $3,233,152, $2,823,971 and $3,318,007 at December 31, 2012, September 30, 2012 and December 31, 2011, respectively. The decrease of approximately $85,000 from December to December is due primarily to the decrease in cash and cash equivalents, prepaid expenses of approximately $670,000 and $16,000 respectively, offset by increases in accounts receivable and inventory of approximately $563,000 and $37,000 respectively. The decrease in cash and cash equivalents combined with the increase in accounts receivable was due to the large order obtained in October of 2012 for an OEM supplier. The increase from September 30, 2012 to December 31, 2012 is due primarily to the increase in accounts receivable and inventory of approximately $427,000 and $135,000 respectively, offset in part by the decrease in cash and cash equivalents and prepaid expenses of approximately $103,000 and $50,000 respectively. The increase in accounts receivable and inventory was due primarily to the production and shipment of the large order obtained in October of 2012 for an OEM supplier.

Working capital as of December 31, 2012 amounted to $2,325,571 as compared with $2,306,513 a year earlier. Current assets were 3.6 times current liabilities and total cash and cash equivalents and receivables were 1.4 times current liabilities. These ratios compare to 3.3 and 1.4, respectively, at December 31, 2011.

Internally generated funds during the three months ended December 31, 2012 were a negative $181,561. There were no capital expenditures during the period. The primary reason for the negative cash flow from operations was the increase in accounts receivable and inventory of approximately $427,000 and $135,000 respectively offset in part by the net income during the current quarter. The Company does not anticipate any material capital expenditures during fiscal 2013. In addition, the Company believes that cash and cash equivalents together with funds anticipated to be generated by operations in addition to available short-term financing will provide adequate funding of the Company's working capital needs.

Shareholders' equity during the three months ended December 31, 2012 increased by $363,061 which was the net income during the period of $143,804, sale of Class A Conversion shares of $208,591, issuance of Class A Common shares for consulting services of $7,000, share-based compensation expense of $2,841, non-cash interest expense on warrants issued of $22,750 and filing fees for additional authorized common shares of $21,925.

On October 11, 2012, the Company's Amended Articles of Incorporation and the Amended Code of Regulations were adopted by an affirmative vote of more than two-thirds of the Company's Class A and Class B Shareholders.

The Amended Articles amend and restate the Current Articles in a number of significant ways and are primarily as follows: increased the number of Class A Shares and Class B Shares from 3,750,000 and 1,000,000 to 10,000,000 and 2,500,000 respectively, and added a class of 1,000,000 Serial Preferred Shares; eliminated par value for for Class A Shares and Class B Shares; updated certain provisions relating to the payment of dividends; removed restrictions on the issuance of additional Class A Shares; clarified the method by which the Company may repurchase its shares; reduced the percentage of shareholder vote required to authorize corporate actions from two-thirds of the voting power to a majority of the voting power; and made other technical or conforming changes.

The Amended Regulations amend and restate the Current Regulations in a number of significant ways and are primarily as follows: updated certain provisions relating to the Company's meetings of shareholders in order to provide more consistency in the regulations regarding the Company's practices in this area; further clarifying the roles of the Company's officers and directors in conducting the Company's business; updated the Company's policy regarding the indemnification of its directors, officers, employees, and others; revised provisions allowing for the Board of Directors to adopt amendments to the Amended Regulations to the extent permitted by Ohio law; and made other technical or conforming changes.  

Detailed information related to the two changes approved by shareholders may be found in the 2012 Proxy Statement for the Special Meeting held October 11, 2012 which was filed with the Securities and Exchange Commission on September 14, 2012.

During fiscal 2013 the Company's business may require a short-term increase in inventory and accounts receivables. Whenever there may be a requirement to increase inventory in fiscal 2013 there will be a negative but temporary impact on liquidity. The Company has reduced wages, headcount, product development, and marketing, administrative and sales related expenses in order to appropriately manage its working capital. The Company believes that internally generated funds and available short-term financing will provide sufficient liquidity to meet ongoing working capital requirements.

Off-Balance Sheet Arrangements

Hickok has no off-balance sheet arrangements (as defined in Regulation S-K Item 303 paragraph (a)(4)(ii)) that have or are reasonably likely to have a material current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

Our critical accounting policies are as presented in Notes to Consolidated Financial Statements and Management's Discussion and Analysis of Financial Condition and Results of Operation in our Form 10-K for the year ended September 30, 2012.

Forward-Looking Statements

The foregoing discussion includes forward-looking statements relating to the business of the Company. These forward-looking statements, or other statements made by the Company, are made based on management's expectations and beliefs concerning future events impacting the Company and are subject to uncertainties and factors (including, but not limited to, those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. As a result, actual results of the Company could differ materially from those expressed in or implied by any such forward-looking statements. These uncertainties and factors include (a) the Company's dependence upon a limited number of customers and the automotive industry, (b) the highly competitive industry in which the company operates, which includes several competitors with greater financial resources and larger sales organizations, (c) the acceptance in the marketplace of new products and/or services developed or under development by the Company including automotive diagnostic products and indicating instrument products, (d) the ability of the Company to further establish distribution and a customer base in the automotive aftermarket, (e) the Company's ability to capitalize on market opportunities including state automotive emissions programs and OEM tool programs and (f) the Company's ability to obtain cost effective financing.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Market Risk

The Company is exposed to certain market risks from transactions that are entered into during the normal course of business. The Company has not entered into derivative financial instruments for trading purposes. The Company's primary market risks are exposure related to interest rate risk and equity market fluctuations. The Company's only debt subject to interest rate risk is its revolving credit facility. The Company has a balance of $100,000 on its credit facility at December 31, 2012, which is subject to a fixed rate of interest of 0.24%. As a result, the Company believes that the market risk related to interest rate movements is minimal.

Item 4. Controls and Procedures.

As of December 31, 2012, an evaluation was performed, under the supervision and with the participation of the Company's management, including the Company's Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based upon that evaluation, the Company's management, including the Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, concluded that the Company's disclosure controls and procedures were effective as of December 31, 2012 in ensuring that information required to be disclosed by the Company in the reports it files and submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. There were no changes in the Company's internal controls over financial reporting during the first fiscal quarter ended December 31, 2012 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. There has been no material developments in this legal proceeding since the filing of Form 10-K for fiscal 2012. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of the patent infringement matter will have on the Company's results of operations, financial position or cash flows.

The Company is a named defendant along with numerous other companies in a suit in the State of Michigan regarding asbestos harm to the plaintiff. The Company has engaged a Michigan attorney to provide representation. There has been no material developments in this legal proceeding since the filing of Form 10-K for fiscal 2012. The Company believes the suit is without merit and is pursuing dismissal of the case.

Item 6. Exhibits.

Exhibit No.	Description
11	Statement Regarding Computation of Earnings Per Share and Common Share Equivalents
31.1	Rule 13a-14(a)/15d-14(a) Certification by the Chief Executive Officer
31.2	Rule 13a-14(a)/15d-14(a) Certification by the Chief Financial Officer
32.1	Certification by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS**	XBRL Instance
101.SCH**	XBRL Taxonomy Extension Schema
101.CAL**	XBRL Taxonomy Extension Calculation
101.DEF**	XBRL Extension Definition
101.LAB**	XBRL Taxonomy Extension Labels
101.PRE**	XBRL Taxonomy Extension Presentation

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		HICKOK INCORPORATED (Registrant)
Date: February 14, 2013	/s/ R. L. Bauman
	R. L. Bauman, Chief Executive Officer, President, and Treasurer
Date: February 14, 2013	/s/ G. M. Zoloty
	G. M. Zoloty, Chief Financial Officer

EX-11

FORM 10-Q

EXHIBIT 11

HICKOK INCORPORATED
CONSOLIDATED STATEMENT OF COMPUTATION OF EARNINGS
PER COMMON SHARE AND COMMON SHARE EQUIVALENTS

Three Months Ended
December 31,
2012	2011

NET INCOME Net income (loss) applicable to common shares for basic earnings per share	$143,804	$(183,140)
Net income (loss) applicable to common shares for diluted earnings per share	$143,804	$(183,140)
SHARES OUTSTANDING Weighted average shares for basic earnings per share	1,528,541	1,251,273
Net effect of dilutive stock options - based on the treasury stock method using year-end market price, if higher than average market price	12,942	-*
Total shares for diluted earnings per share	1,541,483	1,251,273
Basic Earnings Per Common Share	$.09	$(.15)
Diluted Earnings Per Common Share	$.09	$(.15)

*  Net effect of stock options was antidilutive for the period.
   
   

EX-31

Form 10-Q

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Robert L. Bauman, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hickok Incorporated (the "registrant");
    

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
   b) Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
   c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
   d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
   
   

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:

/s/ R. L. Bauman

R. L. Bauman

Chief Executive Officer

February 14, 2013

EX-31

Form 10-Q

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Gregory M. Zoloty, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hickok Incorporated (the "registrant");
    

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
   b) Designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
   c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
   d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
   
   

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:

/s/ G. M. Zoloty

G. M. Zoloty

Vice President, Finance
and Chief Financial Officer

February 14, 2013

EX-32

Form 10-Q

Exhibit 32.1

CERTIFICATION PURSUANT TO

18U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hickok Incorporated (the "Company") on Form 10-Q for the period ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert L. Bauman, Chief Executive Officer of the Company, certify, pursuant to 18U.S.C.section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ R. L. Bauman

R. L. Bauman

Chief Executive Officer

February 14, 2013

EX-32

Form 10-Q

Exhibit 32.2

CERTIFICATION PURSUANT TO

18U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Hickok Incorporated (the "Company") on Form 10-Q for the period ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gregory M. Zoloty, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ G. M. Zoloty

G. M. Zoloty

Chief Financial Officer

February 14, 2013

XML

Note 9 - Segment and Related Information (Detail) - Information by industry segment is set forth below: (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Sep. 30, 2012
Net Sales
Net Sales	$ 1,738,903	$ 1,181,501
Income (Loss) before Provision for Income Taxes
Income (Loss) before Provision for Income Taxes	143,804	(183,140)
Asset Information
Asset Information	3,588,517	3,722,466	3,205,971
Indicators and Gauges [Member]
Net Sales
Net Sales	410,226	378,003
Income (Loss) before Provision for Income Taxes
Income (Loss) before Provision for Income Taxes	111,624	57,465
Asset Information
Asset Information	831,059	729,421
Automotive Diagnostic Tools and Equipment [Member]
Net Sales
Net Sales	1,328,677	803,498
Income (Loss) before Provision for Income Taxes
Income (Loss) before Provision for Income Taxes	307,465	(15,256)
Asset Information
Asset Information	2,167,252	1,667,391
General Corporate Expenses [Member]
Income (Loss) before Provision for Income Taxes
Income (Loss) before Provision for Income Taxes	(275,285)	(225,349)
Total [Member]
Income (Loss) before Provision for Income Taxes
Income (Loss) before Provision for Income Taxes	143,804	(183,140)
Asset Information
Asset Information	3,588,517	3,722,466
Corporate [Member]
Asset Information
Asset Information	590,206	1,325,654
United States [Member]
Revenue:
Geographical Information - Revenue	1,700,435	1,112,633
Australia [Member]
Revenue:
Geographical Information - Revenue		12,053
Canada [Member]
Revenue:
Geographical Information - Revenue	28,054	13,752
Taiwan [Member]
Revenue:
Geographical Information - Revenue		32,405
Other Foreign Countries [Member]
Revenue:
Geographical Information - Revenue	10,414	10,658
Total [Member]
Revenue:
Geographical Information - Revenue	$ 1,738,903	$ 1,181,501

XML

Note 3 - Notes Receivable (Detail)	3 Months Ended
	Dec. 31, 2012
Note Receivable Percentage	3.00%

XML

Note 4 - Convertible Notes Payable

3 Months Ended

Dec. 31, 2012

Debt Disclosure [Text Block]

4. Convertible Notes Payable

On December 30, 2011, Hickok Incorporated entered into a Convertible Loan Agreement with Roundball, LLC and the Aplin Family Trust. Under the Convertible Loan Agreement, the Company issued a convertible note to Roundball in the amount of $466,879 and a convertible note to the Aplin Family Trust in the amount of $208,591. In addition, Roundball, LLC shall have the right to cause the Company to borrow up to an additional $466,880 from Roundball, LLC. The notes were unsecured, bore interest at a rate of 0.20% per annum and were set to mature on December 30, 2012.

In addition, the Company sold 20,000 Class B Common Shares currently held in treasury to Roundball at a price of $1.85 per share per a subscription agreement between the Company and Roundball dated December 30, 2011.

The notes were convertible by the Investors at any time into Class A Common Shares of the Company, at a conversion price of $1.85 per share, although up to no more than 504,735 Conversion Shares for Roundball and no more than 112,752 Conversion Shares for the Aplin Family Trust. The Company had the option to convert the notes at the expiration date, if the investors had not during the course of the agreement. On December 30, 2011, Roundball converted $233,438 into Class A Common Shares of the Company. In addition, on August 20, 2012 Roundball converted the remaining $233,441 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 28, 2012, the Aplin Family Trust converted the $208,591 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 30, 2012 management entered into an amended Convertible Loan Agreement with Roundball which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2012 to December 31, 2013 and modifying the terms to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.24%.

In partial consideration for Amendment No. 1, the Company and Roundball entered into a Warrant Agreement, dated  December 30, 2012, whereby the Company issued a warrant to the Roundball to purchase, at its option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015. Roundball is an affiliate of Steven Rosen, a Director of the Company.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued is amortized over the one year amended convertible loan agreement period. During the quarter ended December 31, 2012, $11,375 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the three month period ended December 31, 2012: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

XML

Note 6 - Capital Stock, Treasury Stock, Contributed Capital and Stock Options: (Detail) - Summary of the range of exercise prices for stock options outstanding and exercisable under the Director Plans: (Directors Plans [Member], USD $)	3 Months Ended
	Dec. 31, 2012
Exercise Price Range $2.925 To $5.25 [Member]
Lower Exercise Price Range	$ 2.925
Number of Stock Options Exercisable (in Shares)	23,000
Weighted Average Share Price	$ 3.43
Weighted Average Remaining Life	6 years 109 days
Number of Stock Options Exercisable (in Shares)	12,667
Weighted Average Share Price	$ 3.84
Upper Exercise Price Range	$ 5.25
Exercise Price Range $6.00 To $7.25 [Member]
Lower Exercise Price Range	$ 6.00
Number of Stock Options Exercisable (in Shares)	11,000
Weighted Average Share Price	$ 6.46
Weighted Average Remaining Life	4 years 109 days
Number of Stock Options Exercisable (in Shares)	9,333
Weighted Average Share Price	$ 6.55
Upper Exercise Price Range	$ 7.25
Exercise Price Range $10.50 To $11.00 [Member]
Lower Exercise Price Range	$ 10.50
Number of Stock Options Exercisable (in Shares)	8,000
Weighted Average Share Price	$ 10.75
Weighted Average Remaining Life	4 years 292 days
Number of Stock Options Exercisable (in Shares)	8,000
Weighted Average Share Price	$ 10.75
Upper Exercise Price Range	$ 11.00
Total [Member]
Number of Stock Options Exercisable (in Shares)	42,000
Weighted Average Share Price	$ 5.62
Number of Stock Options Exercisable (in Shares)	30,000
Weighted Average Share Price	$ 6.52

XML

Note 6 - Capital Stock, Treasury Stock, Contributed Capital and Stock Options: (Detail) (USD $)	3 Months Ended													3 Months Ended	27 Months Ended	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012 Common Class A [Member] Directors Plans [Member]	Dec. 31, 2012 Common Class A [Member] Minimum [Member]	Dec. 31, 2012 Common Class A [Member] Maximum [Member]	Dec. 31, 2012 Common Class A [Member]	Sep. 30, 2012 Common Class A [Member]	Dec. 31, 2011 Common Class A [Member]	Dec. 31, 2012 Common Class B [Member] Minimum [Member]	Dec. 31, 2012 Common Class B [Member] Maximum [Member]	Dec. 31, 2012 Common Class B [Member]	Sep. 30, 2012 Common Class B [Member]	Dec. 31, 2011 Common Class B [Member]	Dec. 31, 2011 Employee Plans [Member]	Dec. 31, 2012 Employee Plans [Member]	Dec. 31, 2012 Directors Plans [Member]	Dec. 31, 2011 Directors Plans [Member]	Sep. 30, 2012 Directors Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term															10 years
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options			42,000											26,850		38,000	38,000	42,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in Dollars per share)														$ 3.55			$ 2.925
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in Dollars per share)																	$ 11.00
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term																3 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period																3 years
Share-based Compensation (in Dollars)	$ 2,841	$ 2,865														$ 2,841	$ 2,865
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate																5.50%	5.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term																10 years	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate																0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate																0.87%	0.75%
Common Stock, Shares Authorized	1,000,000			3,750,000	10,000,000	10,000,000	10,000,000	10,000,000	1,000,000	2,500,000	2,500,000	2,500,000	12,500,000
Common Stock, Capital Shares Reserved for Future Issuance											769,233

XML

Note 8 - Earnings per Common Share (Detail) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Stock Options [Member] | Minimum [Member]
Share Price		2.925
Stock Options [Member] | Maximum [Member]
Share Price		11.00
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	42,000	64,850
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	200,000
Options And Warrants [Member] | Minimum [Member]
Share Price	2.50
Options And Warrants [Member] | Maximum [Member]
Share Price	11.00
Conversion Rights [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)		491,304
Share Price		1.85

XML

Note 8 - Earnings per Common Share (Detail) - Summary of earnings per share calculation: (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Basic Income (Loss) per Share
Income (Loss) available to common stockholders (in Dollars)	$ 143,804	$ (183,140)
Shares denominator	1,528,541	1,251,273
Per share amount (in Dollars per share)	$ 0.09	$ (0.15)
Effect of Dilutive Securities
Average shares outstanding	1,528,541	1,251,273
Stock options	12,942
	1,541,483	1,251,273
Diluted Income (Loss) per Share
Income (Loss) available to common stockholders (in Dollars)	$ 143,804	$ (183,140)
Per share amount (in Dollars per share)	$ 0.09	$ (0.15)

XML

Note 3 - Notes Receivable

3 Months Ended

Dec. 31, 2012

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

3. Notes Receivable

The Company has notes receivable with a current and former employee at an interest rate of three percent per annum. The Company does not anticipate repayment within the next twelve months.

XML

Note 9 - Segment and Related Information (Detail)	3 Months Ended
	Dec. 31, 2012
Number of Operating Segments	4
Number of Reportable Segments	2

XML

Consolidated Income Statements (Unaudited) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Net Sales
Product Sales	$ 1,647,435	$ 1,110,740
Service Sales	91,468	70,761
Total Net Sales	1,738,903	1,181,501
Costs and Expenses
Cost of Product Sold	892,133	729,105
Cost of Service Sold	34,269	59,684
Product Development	231,147	224,737
Marketing and Administrative Expenses	417,243	349,641
Interest Charges	22,855	3,995
Other Income	(2,548)	(2,521)
Total Costs and Expenses	1,595,099	1,364,641
Income (Loss) before Provision for Income Taxes	143,804	(183,140)
Provision for (Recovery of) Income Taxes
Net Income (Loss)	$ 143,804	$ (183,140)
Earnings per Common Share:
Net Income (Loss) (in Dollars per share)	$ 0.09	$ (0.15)
Earnings per Common Share Assuming Dilution:
Net Income (Loss) (in Dollars per share)	$ 0.09	$ (0.15)
Dividends per Common Share (in Dollars per share)	$ 0	$ 0

XML

Note 1 - Basis of Presentation

3 Months Ended

Dec. 31, 2012

Basis of Accounting [Text Block]

1. Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended December 31, 2012 are not necessarily indicative of the results that may be expected for the year ended September 30, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended September 30, 2012.

XML

Note 9 - Segment and Related Information (Tables)

3 Months Ended

Dec. 31, 2012

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months ended December 31,
	2012			2011
Net Sales
Indicators and Gauges	$	410,226		$	378,003
Automotive Diagnostic Tools and Equipment		1,328,677			803,498
	$	1,738,903		$	1,181,501
Income (Loss) before Provision for Income Taxes
Indicators and Gauges	$	111,624		$	57,465
Automotive Diagnostic Tools and Equipment		307,465			(15,256	)
General Corporate Expenses		(275,285	)		(225,349	)
	$	143,804		$	(183,140	)
Asset Information
Indicators and Gauges	$	831,059		$	729,421
Automotive Diagnostic Tools and Equipment		2,167,252			1,667,391
Corporate		590,206			1,325,654
	$	3,588,517		$	3,722,466
Geographical Information
Included in the consolidated financial statements are the following amounts related to geographical locations:
Revenue:
United States	$	1,700,435		$	1,112,633
Australia		-			12,053
Canada		28,054			13,752
Taiwan		-			32,405
Other foreign countries		10,414			10,658
	$	1,738,903		$	1,181,501

XML

Note 2 - Inventories (Detail) - Inventories are valued at the lower of cost or market and consist of the following: (USD $)	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Components	$ 1,036,824	$ 1,061,957	$ 1,051,776
Work-in-Process	596,926	451,733	486,813
Finished Product	236,369	221,080	294,827
	$ 1,870,119	$ 1,734,770	$ 1,833,416

XML

Note 2 - Inventories

3 Months Ended

Dec. 31, 2012

Inventory Disclosure [Text Block]

2. Inventories

Inventories are valued at the lower of cost or market and consist of the following:

	December 31, 2012		September 30, 2012		December 31, 2011
Components	$	1,036,824	$	1,061,957	$	1,051,776
Work-in-Process		596,926		451,733		486,813
Finished Product		236,369		221,080		294,827
	$	1,870,119	$	1,734,770	$	1,833,416

The above amounts are net of reserve for obsolete inventory in the amount of $883,903, $851,000 and $762,000 for the periods ended December 31, 2012, September 30, 2012 and December 31, 2011 respectively.

XML

Consolidated Balance Sheet (Unaudited) (USD $)	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Current Assets
Cash and Cash Equivalents	$ 156,212	$ 258,798	$ 826,348
Trade Accounts Receivable-Net	1,129,405	702,846	566,386
Notes Receivable-Current	3,600	3,600	2,400
Inventories	1,870,119	1,734,770	1,833,416
Prepaid Expenses	73,816	123,957	89,457
Total Current Assets	3,233,152	2,823,971	3,318,007
Property, Plant and Equipment
Land	233,479	233,479	233,479
Buildings	1,429,718	1,429,718	1,429,718
Machinery and Equipment	2,374,319	2,374,319	2,346,024
	4,037,516	4,037,516	4,009,221
Less: Allowance for Depreciation	3,714,001	3,688,266	3,641,412
Total Property - Net	323,515	349,250	367,809
Notes Receivable-Long-term	30,100	31,000	34,900
Deposits	1,750	1,750	1,750
Total Other Assets	31,850	32,750	36,650
Total Assets	3,588,517	3,205,971	3,722,466
Current Liabilities
Short-Term Financing	100,000		250,000
Convertible Notes Payable		208,591	233,441
Trade Accounts Payable	292,341	178,835	143,156
Accrued Payroll & Related Expenses	132,443	149,636	122,905
Accrued Expenses	323,365	306,475	199,312
Accrued Taxes Other Than Income	59,432	44,559	62,680
Total Current Liabilities	907,581	888,096	1,011,494
Stockholders' Equity
Contributed Capital	1,413,306	1,409,640	1,328,096
Retained Earnings	(468,424)	(612,228)	(11,402)
Total Stockholders' Equity	2,680,936	2,317,875	2,710,972
Total Liabilities and Stockholders' Equity	3,588,517	3,205,971	3,722,466
Common Class A [Member]
Stockholders' Equity
Class of common stock - value	1,261,188	1,045,597	919,412
Common Class B [Member]
Stockholders' Equity
Class of common stock - value	$ 474,866	$ 474,866	$ 474,866

XML

Note 12 - Business Condition and Management Plan

3 Months Ended

Dec. 31, 2012

Going Concern Note

12. Business Condition and Management Plan

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has suffered recurring losses from operations during the past several years due primarily to decreasing sales of existing product lines and a general economic downturn in all markets the Company serves.

The ability of the Company to continue as a going concern is dependent on improving the Company's profitability and cash flow and securing additional financing if needed. Management continues to review and revise its strategic plan and believes in the viability of its strategy to increase revenues and profitability through increased sales of existing products and the introduction of new products to the market place. Management believes that the actions presently being taken by the Company will provide the stimulus for it to continue as a going concern, however, because of the inherent uncertainties there can be no assurances to that effect. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Management took steps to reduce expenses throughout the Company in fiscal 2009, 2010 and 2011 in the form of substantial reductions in personnel, wage reductions for all personnel and expenditure restrictions in most aspects of the Company’s operations. Anticipated cost savings were achieved during the past four years and management expects these measures to continue through fiscal 2013. During the first quarter of fiscal 2012 management entered into two unsecured convertible loan agreements that have provided approximately $675,000 of cash to date. One of the convertible loan agreements was fully converted during fiscal 2012 and the other on December 28, 2012.

In addition, on December 30, 2012 management entered into an amended unsecured convertible loan agreement and an additional revolving line of credit which may provide approximately $717,000 of liquidity to meet on going working capital requirements. One agreement is an unsecured revolving line of credit with a major shareholder who is also an employee and the other is an unsecured convertible loan agreement with a major shareholder who is also a Director as discussed in Notes 4 and 5. These facilities are available through December 2013.

The above available financing resources together with management’s revised strategic plan to increase revenues and profitability through increased sales of existing products, the introduction of new products to the market place and the large order from a Tier 1 Supplier should provide the Company with the needed working capital for the foreseeable future.

XML

Document And Entity Information	3 Months Ended
	Dec. 31, 2012	Feb. 08, 2013 Common Class A [Member]	Feb. 08, 2013 Common Class B [Member]
Entity Registrant Name	HICKOK INC
Document Type	10-Q
Current Fiscal Year End Date	--09-30
Entity Common Stock, Shares Outstanding		1,163,349	474,866
Amendment Flag	false
Entity Central Index Key	0000047307
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2012
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q1

XML

Accounting Policies, by Policy (Policies)

3 Months Ended

Dec. 31, 2012

Business Description and Basis of Presentation [Text Block]

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended December 31, 2012 are not necessarily indicative of the results that may be expected for the year ended September 30, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended September 30, 2012.

XML

Consolidated Balance Sheet (Unaudited) (Parentheticals) (USD $)	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Class of common stock - shares authorized	1,000,000
Common Class A [Member]
Class of common stock - par value (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00
Class of common stock - shares authorized	10,000,000	10,000,000	10,000,000
Class of common stock - shares outstanding	1,163,349	1,045,597	919,412
Class of common stock - excluding shares in treasury	15,795	15,795	15,795
Common Class B [Member]
Class of common stock - par value (in Dollars per share)	$ 0.00	$ 0.00	$ 0.00
Class of common stock - shares authorized	2,500,000	2,500,000	12,500,000
Class of common stock - shares outstanding	474,866	474,866	474,866
Class of common stock - excluding shares in treasury	667	667	667

XML

Note 7 - Recently Issued Accounting Pronouncements

3 Months Ended

Dec. 31, 2012

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

7. Recently Issued Accounting Pronouncements

The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.

XML

Note 6 - Capital Stock, Treasury Stock, Contributed Capital and Stock Options:

3 Months Ended

Dec. 31, 2012

Stockholders' Equity Note Disclosure [Text Block]

6. Capital Stock, Treasury Stock, Contributed Capital and Stock Options

Under the Company's Key Employees Stock Option Plans (collectively the "Employee Plans"), incentive stock options, in general, are exercisable for up to ten years, at an exercise price of not less than the market price on the date the option is granted. Under the Employee Plans there are no options currently available for grant and there are no options outstanding at December 31, 2012. Options for 26,850 Class A shares were outstanding at December 31, 2011 at a price of $3.55 per share.

The Company's Outside Directors Stock Option Plans (collectively the "Directors Plans"), provide for the automatic grant of options to purchase up to 38,000 shares of Class A Common Stock to members of the Board of Directors who are not employees of the Company, at the fair market value on the date of grant. Options for 42,000 Class A shares were outstanding at December 31, 2012 (42,000 shares at September 30, 2012 and 38,000 shares at December 31, 2011) at prices ranging from $2.925 to $11.00 per share. All outstanding options under the Directors Plans become fully exercisable on March 8, 2015.

The following is a summary of the range of exercise prices for stock options outstanding and exercisable under the Directors Plans at December 31, 2012:

Directors Plans				Outstanding Stock Options		Weighted Average Share Price		Weighted Average Remaining Life		Number of Stock Options  Exercisable		Weighted Average Share Price
Range of exercise prices:
$	2.925	-	$5.25		23,000	$	3.43		6.3		12,667	$	3.84
$	6.00	-	$7.25		11,000	$	6.46		4.3		9,333	$	6.55
$	10.50	-	$11.00		8,000	$	10.75		4.8		8,000	$	10.75
					42,000	$	5.62				30,000	$	6.52

The Company accounts for Share-Based Payments under the modified prospective method for its stock options for both employees and non-employee Directors. Compensation cost for fixed based awards are measured at the grant date, and the Company uses the Black-Scholes option pricing model to determine the fair value estimates for recognizing the cost of employee and director services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. Employee stock options were immediately exercisable while Director's stock options are exercisable over a three year period. The fair value of stock option grants to Directors is amortized over the three year vesting period. During the quarter ended December 31, 2012 $2,841 was expensed as share-based compensation. During the quarter ended December 31, 2011 $2,865 was expensed as share-based compensation. The following weighted-average assumptions were used in the option pricing model for the three month periods ended December 31, 2012 and 2011 respectively: a risk free interest rate of 5.5% and 5.5%; an expected life of 10 and 10 years; an expected dividend yield of 0.0% and 0.0%; and a volatility factor of .87 and .75.

On October 11, 2012, the Company's Amended Articles of Incorporation and the Amended Code of Regulations were adopted by an affirmative vote of more than two-thirds of the Company's Class A and Class B Shareholders.

The Amended Articles amend and restate the Current Articles in a number of significant ways and are primarily as follows: increased the number of Class A Shares and Class B Shares from 3,750,000 and 1,000,000 to 10,000,000 and 2,500,000 respectively, and added a class of 1,000,000 Serial Preferred Shares; eliminated par value for for Class A Shares and Class B Shares; updated certain provisions relating to the payment of dividends; removed restrictions on the issuance of additional Class A Shares; clarified the method by which the Company may repurchase its shares; reduced the percentage of shareholder vote required to authorize corporate actions from two-thirds of the voting power to a majority of the voting power; and made other technical or conforming changes.

The Amended Regulations amend and restate the Current Regulations in a number of significant ways and are primarily as follows: updated certain provisions relating to the Company's meetings of shareholders in order to provide more consistency in the regulations regarding the Company's practices in this area; further clarifying the roles of the Company's officers and directors in conducting the Company's business; updated the Company's policy regarding the indemnification of its directors, officers, employees, and others; revised provisions allowing for the Board of Directors to adopt amendments to the Amended Regulations to the extent permitted by Ohio law; and made other technical or conforming changes.  

Detailed information related to the two changes approved by shareholders may be found in the 2012 Proxy Statement for the Special Meeting held October 11, 2012 which was filed with the Securities and Exchange Commission on September 14, 2012.

Unissued shares of Class A common stock (769,233 shares) are reserved for the share-for-share conversion rights of the Class B common stock, stock options under the Directors Plans, conversion rights of the Convertible Promissory Note and available warrants.

XML

Note 2 - Inventories (Detail) (USD $)	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Inventory Valuation Reserves	$ 883,903	$ 851,000	$ 762,000

XML

Note 2 - Inventories (Tables)

3 Months Ended

Dec. 31, 2012

Schedule of Inventory, Current [Table Text Block]

	December 31, 2012		September 30, 2012		December 31, 2011
Components	$	1,036,824	$	1,061,957	$	1,051,776
Work-in-Process		596,926		451,733		486,813
Finished Product		236,369		221,080		294,827
	$	1,870,119	$	1,734,770	$	1,833,416

XML

Note 10 - Commitments and Contingencies

3 Months Ended

Dec. 31, 2012

Commitments and Contingencies Disclosure [Text Block]

10. Commitments and Contingencies

Legal Matters

The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the Company's results of operations, financial position or cash flows.

The Company is a named defendant along with numerous other companies in a suit in the State of Michigan regarding asbestos harm to the plaintiff. The Company has engaged a Michigan attorney to provide representation. The Company believes the suit is without merit and is pursuing dismissal of the case.

XML

Note 8 - Earnings per Common Share

3 Months Ended

Dec. 31, 2012

Earnings Per Share [Text Block]

8. Earnings per Common Share

Earnings per common share information is computed on the weighted average number of shares outstanding during each period based on the provisions of FASB Codification ASC Topic 260, "Earnings per Share."  The required reconciliations are as follows:

	Three Months ended December 31,
	2012		2011
Basic Income (Loss) per Share
Income (Loss) available to common stockholders	$	143,804	$	(183,140	)
Shares denominator		1,528,541		1,251,273
Per share amount	$	.09	$	(.15	)
Effect of Dilutive Securities
Average shares outstanding		1,528,541		1,251,273
Stock options		12,942		-
		1,541,483		1,251,273
Diluted Income (Loss) per Share
Income (Loss) available to common stockholders	$	143,804	$	(183,140	)
Per share amount	$	.09	$	(.15	)

Options and warrants to purchase 42,000 and 200,000 shares of common stock respectively during the first quarter of fiscal 2013 at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

Options to purchase 64,850 shares of common stock during the first quarter of fiscal 2012 at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In addition, conversion rights to purchase 491,304 shares of common stock at a price of $1.85 per share were not included in the computation of diluted earnings per share during the first quarter of fiscal 2012 because the conversion rights of the Convertible Promissory Notes effect was antidilutive or the exercise price was greater than the average market price of the common share.

XML

Note 9 - Segment and Related Information

3 Months Ended

Dec. 31, 2012

Segment Reporting Disclosure [Text Block]

9. Segment and Related Information

The Company's four business units have a common management team and infrastructure that offer different products and services. The business units have been aggregated into two reportable segments: 1.)indicators and gauges and 2.)automotive related diagnostic tools and equipment.

Indicators and Gauges

This segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to both original equipment manufacturers and to operators of railroad equipment.

Automotive Diagnostic Tools and Equipment

This segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEM's and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions.

Information by industry segment is set forth below:

	Three Months ended December 31,
	2012			2011
Net Sales
Indicators and Gauges	$	410,226		$	378,003
Automotive Diagnostic Tools and Equipment		1,328,677			803,498
	$	1,738,903		$	1,181,501
Income (Loss) before Provision for Income Taxes
Indicators and Gauges	$	111,624		$	57,465
Automotive Diagnostic Tools and Equipment		307,465			(15,256	)
General Corporate Expenses		(275,285	)		(225,349	)
	$	143,804		$	(183,140	)
Asset Information
Indicators and Gauges	$	831,059		$	729,421
Automotive Diagnostic Tools and Equipment		2,167,252			1,667,391
Corporate		590,206			1,325,654
	$	3,588,517		$	3,722,466
Geographical Information
Included in the consolidated financial statements are the following amounts related to geographical locations:
Revenue:
United States	$	1,700,435		$	1,112,633
Australia		-			12,053
Canada		28,054			13,752
Taiwan		-			32,405
Other foreign countries		10,414			10,658
	$	1,738,903		$	1,181,501

All export sales to Australia, Canada, Taiwan and other foreign countries are made in United States of America Dollars.

XML

Note 11 - Subsequent Events

3 Months Ended

Dec. 31, 2012

Subsequent Events [Text Block]

11. Subsequent Events

The Company has evaluated subsequent events through February 7, 2013, which is the date the financial statements were available to be issued, and has determined there were no subsequent events to recognize or disclose in these financial statements.

XML

Note 12 - Business Condition and Management Plan (Detail) (USD $)	Dec. 30, 2012	Dec. 28, 2012
Working Capital Funding	$ 467,000	$ 675,000
Amended Loan Agreement [Member]
Working Capital Funding	$ 717,000

XML

Note 8 - Earnings per Common Share (Tables)

3 Months Ended

Dec. 31, 2012

Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block]

	Three Months ended December 31,
	2012		2011
Basic Income (Loss) per Share
Income (Loss) available to common stockholders	$	143,804	$	(183,140	)
Shares denominator		1,528,541		1,251,273
Per share amount	$	.09	$	(.15	)
Effect of Dilutive Securities
Average shares outstanding		1,528,541		1,251,273
Stock options		12,942		-
		1,541,483		1,251,273
Diluted Income (Loss) per Share
Income (Loss) available to common stockholders	$	143,804	$	(183,140	)
Per share amount	$	.09	$	(.15	)

XML

Note 4 - Convertible Notes Payable (Detail) (USD $)	3 Months Ended					3 Months Ended		1 Months Ended	3 Months Ended	1 Months Ended	3 Months Ended
	Dec. 30, 2012	Dec. 31, 2012	Dec. 31, 2011	Dec. 28, 2012	Sep. 30, 2012	Dec. 31, 2012 Interest Expense [Member]	Dec. 30, 2011 Common Class B [Member] Roundball LLC [Member]	Aug. 20, 2012 Common Class A [Member] Roundball LLC [Member]	Dec. 30, 2011 Common Class A [Member] Roundball LLC [Member]	Dec. 28, 2012 Common Class A [Member] Aplin Family Trust [Member]	Dec. 30, 2011 Common Class A [Member] Aplin Family Trust [Member]	Dec. 30, 2012 Common Class A [Member] Amendment No. 1 [Member]	Dec. 31, 2012 Common Class A [Member]	Dec. 30, 2011 Roundball LLC [Member]	Dec. 30, 2012 Aplin Family Trust [Member]	Dec. 30, 2011 Aplin Family Trust [Member]	Dec. 30, 2011 Additional Borrowing [Member]
Convertible Notes Payable, Current			$ 233,441		$ 208,591									$ 466,879		$ 208,591	$ 466,880
Debt Instrument, Interest Rate, Stated Percentage	0.24%														0.20%
Stock Issued During Period, Shares, Other (in Shares)							20,000
Sale of Stock, Price Per Share (in Dollars per share)							$ 1.85
Debt Instrument, Convertible, Conversion Price (in Dollars per share)									$ 1.85
Debt Instrument, Convertible, Number of Equity Instruments									504,735		112,752
Debt Conversion, Converted Instrument, Amount		208,591	233,438					233,441	233,438	208,591
Working Capital Funding	467,000			675,000
Working Capital Funding Borrowing	250,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)												100,000	100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		2.50										2.50	100,000
Debt Instrument Conversion Period		1 year
Other Noncash Expense						$ 11,375
Fair Value Assumptions, Expected Dividend Rate		0.42%
Fair Value Assumptions, Expected Term		3 years
Fair Value Assumptions, Risk Free Interest Rate		0.00%
Fair Value Assumptions, Expected Volatility Rate		0.84%

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Cash Flows from Operating Activities:
Cash received from customers	$ 1,312,344	$ 1,337,846
Cash paid to suppliers and employees	(1,493,998)	(1,277,898)
Interest paid		(3,950)
Interest received	93	170
Net Cash Provided By (Used In) Operating Activities	(181,561)	56,168
Cash Flows from Investing Activities:
Capital expenditures		(9,029)
Payments received on notes receivable	900	800
Net Cash Provided By (Used In) Investing Activities	900	(8,229)
Cash Flows from Financing Activities:
Cost for additional Authorized shares	(21,925)
Increase in Short-term borrowings	100,000
Increase in Convertible Notes Payable		466,879
Sale of Class B shares from treasury		37,000
Net Cash Provided By (Used In) Financing Activities	78,075	503,879
Net increase (decrease) in cash and cash equivalents	(102,586)	551,818
Cash and cash equivalents at beginning of year	258,798	274,530
Cash and cash equivalents at end of first quarter	156,212	826,348
Net Income (Loss)	143,804	(183,140)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	25,735	27,499
Non-cash share-based compensation expense	2,841	2,865
Changes in assets and liabilities:
Decrease (Increase) in accounts receivable	(426,559)	156,345
Decrease (Increase) in inventories	(135,349)	130,527
Decrease (Increase) in prepaid expenses	50,141	(36,190)
Increase (Decrease) in accounts payable	113,506	(30,692)
Increase (Decrease) in accrued payroll and related expenses	(17,193)	(20,044)
Increase (Decrease) in accrued expenses and accrued taxes other than income	31,763	8,998
Total Adjustments	(325,365)	239,308
Net Cash Provided By (Used In) Operating Activities	(181,561)	56,168
Supplemental Schedule of Non-Cash Financing Activities:
Conversion of convertible notes payable to Class A shares	208,591	233,438
Professional Service Expense [Member]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Non-cash expense	7,000
Cash Interest Expense [Member]
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Non-cash expense	$ 22,750

XML

Note 5 - Short-term Financing

3 Months Ended

Dec. 31, 2012

Short-term Debt [Text Block]

5. Short-term Financing

The Company had a credit agreement of $250,000 with Robert L. Bauman, one of its major shareholders who is also an employee of the Company. The agreement was to expire in April 2013 but was modified on December 31, 2012 to extend the maturity date to December 2013. Effective October 30, 2012 for the remainder of the agreement, the lender may terminate the agreement with 45 days written notice, but it is at the discretion of the Company to deny the termination notice until December 2013 if it will have a negative effect on the solvency of the Company.

The agreement provides for a revolving credit facility of $250,000 with interest at 0.24% per annum and is unsecured and includes a three year warrant for 100,000 shares of Class A common stock at a price of $2.50 per share. In addition, the agreement generally allows for borrowing based on an amount equal to eighty percent of eligible accounts receivables or $250,000. The Company had outstanding borrowings of $100,000 under this loan facility at December 31, 2012.

In partial consideration for the extension of the revolving credit facility the Company and Bauman entered into a Warrant Agreement, dated December 30, 2012 whereby the Company issued a warrant to Bauman to purchase, at his option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued is amortized over the one year credit agreement period. During the quarter ended December 31, 2012, $11,375 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the three month period ended December 31, 2012: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

XML

Note 5 - Short-term Financing (Detail) (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Due to Related Parties, Current (in Dollars)	$ 250,000
Line of Credit Facility, Maximum Amount Outstanding During Period (in Dollars)	250,000
Line of Credit Facility, Interest Rate During Period	0.24%
Warrant Period	3 years
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	2.50
Line of Credit Facility, Maximum Borrowing Percentage	80.00%
Line of Credit Facility, Current Borrowing Capacity (in Dollars)	250,000
Short-term Debt (in Dollars)	100,000	250,000
Warrant Agreement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	2.50
Interest Expense, Other (in Dollars)	$ 11,375
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.42%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate	0.84%
Common Class A [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	100,000

XML

Note 6 - Capital Stock, Treasury Stock, Contributed Capital and Stock Options: (Tables) (Directors Plans [Member])

3 Months Ended

Dec. 31, 2012

Directors Plans [Member]

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Directors Plans				Outstanding Stock Options		Weighted Average Share Price		Weighted Average Remaining Life		Number of Stock Options  Exercisable		Weighted Average Share Price
Range of exercise prices:
$	2.925	-	$5.25		23,000	$	3.43		6.3		12,667	$	3.84
$	6.00	-	$7.25		11,000	$	6.46		4.3		9,333	$	6.55
$	10.50	-	$11.00		8,000	$	10.75		4.8		8,000	$	10.75
					42,000	$	5.62				30,000	$	6.52